.
@osfund
is an enthusiastic investor in metal-organic frameworks (MOFs) via
@NuMatTechMOF
. An exciting potential application of this technology is creating new ways to address climate change.
.
@JeffKlunzinger
and I started a venture fund in 2014, OS Fund, after I sold my company Braintree (Venmo). I seeded it with $100M. Here's how it's going so far.
We're thrilled to lead
@ArzedaCo
$15.2m Series A, CEO
@biopraxis
thinks their protein design technology could potentially take the place of the petroleum-based products present in common materials and chemicals from plexiglass to herbicides to sweeteners.
Looking to accelerate the discovery of new therapeutic treatments across diseases? AI-driven drug discovery company,
@twoXAR
, is growing its team. Explore career opportunities in engineering, operations, & business at
With the exciting news of a partnership with
@AldiUSA
, JUST Egg can now be found in 20 of 23 largest US retailers and 10,000 stores nationwide. Congrats to
@eatjust
on this awesome update!
How do you bring safe new drugs to market, faster? OS Fund portfolio company
@AAlphaBio
uses their AlphaSeq technology to sort through millions of protein interactions simultaneously. Learn more at
In this must-read interview with
@business
,
@jrkelly
from
@Ginkgo
talks brewing DNA like it's beer, robots, trustworthy GMOs, $4B, friends as co-founders, and the enormous opportunities that lie ahead in synthetic biology. Check it out at
Congratulations to
@Ginkgo
on the close of their $70M funding from
@illumina
! These funds will be dedicated to scaling Ginkgo's infrastructure and enabling widespread testing with next-generation sequencing (NGS).
OSF portfolio company
@numattech
is utilizing MOFs to design the future of drug delivery. Check out the link below to learn more about the biotechnological applications of MOFs.
We're honored to be able to share that we have been selected by the
@NIH
for a RADx contract, to help enable the scale development of our NGS-based testing technology. Congratulations to our incredible technical team on this milestone / recognition!!
Portfolio company
@Ginkgo
just announced partnerships with accelerators
@ycombinator
and Petri, offering participating startups access to Ginkgo's organism design platform. We can't wait to see what new ideas will be developed through this relationship!
Today is the final day of
@SynbioBeta
2019, but it's jam-packed with great events featuring OS Fund portfolio company team members George McArthur from
@ArzedaCo
, Jason Kakoyiannis from
@Ginkgo
,
@DavidAYounger
from
@AAlphaBio
, and Christina Agapakis from
@Ginkgo
. Don't miss out!